Fibroblast Clinical Trials

9 recruitingLast updated: July 25, 2026

There are 9 actively recruiting fibroblast clinical trials across 6 countries. Studies span Phase 2, Phase 1, Not Applicable, Phase 3. Top locations include Aalborg, Region North Jutland, Denmark, Amsterdam, North Holland, Netherlands, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Fibroblast Trials at a Glance

9 actively recruiting trials for fibroblast are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Aalborg, Amsterdam, and Beijing. Lead sponsors running fibroblast studies include Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Cancer Institute and Hospital, Chinese Academy of Medical Sciences, and Aalborg University Hospital.

Browse fibroblast trials by phase

Treatments under study

About Fibroblast Clinical Trials

Looking for clinical trials for Fibroblast? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fibroblast trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fibroblast clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Keloid Pathogenesis And Fibroblast Activation Study

keloidsFibroblast
The Fourth Affiliated Hospital of Zhejiang University School of Medicine20 enrolled1 locationNCT07682636
Recruiting
Phase 1Phase 2

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting
Phase 1Phase 2

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Anaplastic Large Cell Lymphoma, ALK-PositiveInflammatory Myofibroblastic TumorOther Solid Tumor
Princess Maxima Center for Pediatric Oncology65 enrolled2 locationsNCT04925609
Recruiting
Phase 1

Q702 for the Treatment of Patients With Hematologic Malignancies

Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic46 enrolled2 locationsNCT06712810
Recruiting
Phase 2

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

CancerPleural MesotheliomaPleural Diseases+2 more
Aalborg University Hospital70 enrolled1 locationNCT06790082
Recruiting
Not Applicable

68Ga-FAPI PET/CT in Malignant Tumors

PET/CTMalignant NeoplasmFibroblast Activation Protein Inhibitor
Zhongnan Hospital500 enrolled1 locationNCT05034146
Recruiting

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.

AnemiaCKDFibroblast Growth Factor 23
Maimónides Biomedical Research Institute of Córdoba401 enrolled1 locationNCT05356325
Recruiting
Phase 2Phase 3

Unravelling Intestinal Fibrosis in Ulcerative Colitis

Fibroblast Activation Protein InhibitorUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10 enrolled1 locationNCT06604273
Recruiting
Not Applicable

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

SurgeryFibroblast Activation Protein InhibitorMedullary Thyroid Cancer+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT06277180